Replies to post #687505 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

PIP hasn't even started running trials yet.

SAP for the Plll was lost in space.

It will not be rewarded as LP already told us it won't when she used the word "Extensive".



>>Once NWBO places something like PIP, SAP, MIA or in this case, MAA, before a regulator, the painfully slow preparation has been and/or should be rewarded by reviews with less hiccups and faster evaluations. IMO.